What is Ozempic and does it work for weight loss?

Ozempic is the brand name for semaglutide, a weekly injectable medication manufactured by Novo Nordisk. It was originally approved for type 2 diabetes management and later approved in higher doses as Wegovy specifically for weight loss. Despite being FDA-approved only for diabetes management, Ozempic is widely prescribed off-label for weight loss — it contains the same active ingredient as Wegovy, just at a lower approved dose.

Does it work? Emphatically yes. Semaglutide is the most effective non-surgical weight loss intervention in the history of clinical medicine. The STEP trials showed average weight loss of approximately 15% of body weight over 68 weeks — results that no prior medication had come close to achieving consistently.

~15%
Average body weight lost in STEP clinical trials
87%
Of patients lost at least 5% of body weight
$950
Average monthly cost of brand-name Ozempic without insurance
$99
Starting monthly cost for compounded semaglutide via telehealth

How Ozempic works for weight loss

Semaglutide (Ozempic/Wegovy) is a GLP-1 receptor agonist. GLP-1 is a hormone your gut naturally produces after eating — it signals fullness to the brain, slows how quickly food leaves your stomach, and reduces appetite. Semaglutide mimics this hormone at concentrations much higher than your body naturally produces, creating a sustained reduction in appetite and food intake.

The practical experience most patients describe is not willpower — it's the mental noise around food simply quieting down. Cravings for highly palatable foods reduce. Portions naturally decrease because feeling satisfied happens sooner. The medication changes the biology underlying eating behavior rather than asking patients to white-knuckle through hunger.

This is why it works when dieting doesn't for so many people. Obesity has a strong neurobiological component — hunger hormones and brain reward systems actively resist weight loss. Semaglutide works at the hormonal level to change the underlying biology.

Ozempic vs. Wegovy: Both contain semaglutide. Wegovy is approved specifically for weight loss at a higher dose (2.4mg weekly). Ozempic is approved for diabetes at lower doses (up to 2mg weekly). In practice, many physicians prescribe Ozempic off-label for weight loss. The brand you receive matters less than the dose — and compounded semaglutide at equivalent doses delivers the same outcomes as either brand.

The cost problem — and the solution most people don't know about

Brand-name Ozempic without insurance costs $900–$1,000 per month. Wegovy runs $1,000–$1,100 per month. For the vast majority of people considering GLP-1 therapy, these prices are simply not accessible.

Insurance coverage is inconsistent and frequently denied. Many employer health plans explicitly exclude weight loss medications. Even where coverage exists, prior authorization processes are burdensome and commonly fail.

The solution that has become the dominant access route in 2026: compounded semaglutide through telehealth platforms. Compounded semaglutide uses the identical active molecule at equivalent doses, prescribed by a licensed physician, dispensed by a licensed compounding pharmacy — for $99–$249 per month depending on dose.

This isn't a workaround or a grey area. Compounded medications are a legitimate, legal part of the US pharmaceutical system. The cost difference reflects manufacturing overhead and profit margins, not quality or efficacy differences in the active molecule.

How to get semaglutide affordably in 2026

The most accessible route for most people is through a telehealth platform offering compounded semaglutide. The process is entirely online:

  1. Complete a health intake — 10–15 minutes online. Medical history, current medications, weight loss goals.
  2. Physician review — A licensed clinician reviews your intake and determines whether you qualify. Standard criteria: BMI 30+, or BMI 27–29.9 with a qualifying condition (hypertension, diabetes, high cholesterol, sleep apnea).
  3. Prescription issued — If approved, sent to a licensed compounding pharmacy.
  4. Medication delivered — Ships directly to your door, typically within a week of approval.
  5. Ongoing monitoring — Regular check-ins to adjust dosing and address any issues.

What results to realistically expect

The clinical trial average of 15% body weight loss is a population average — individual results vary considerably. Here's what's realistic:

Timeline: most patients notice appetite changes within 1–2 weeks, visible weight loss begins around weeks 4–8, and meaningful results are apparent by months 3–4. Peak results typically occur in months 6–12. See our detailed week-by-week timeline for the complete picture.

Side effects — what to expect

The most common side effects are gastrointestinal — nausea, vomiting, diarrhea, and constipation. These are most pronounced in the first 4–8 weeks at each new dose level and improve significantly as the body adapts. The titration schedule (starting at low doses and increasing gradually) is specifically designed to minimize these effects.

Serious but less common risks include pancreatitis, gallbladder disease, and a theoretical thyroid risk for patients with specific personal or family histories. These are screened for before prescribing. See our complete side effect guide for practical management strategies.

Is Ozempic or compounded semaglutide right for you?

If you have insurance that covers Ozempic or Wegovy at a manageable copay — use it. The brand-name product has the most established regulatory track record.

For the majority of people without practical insurance coverage, compounded semaglutide through a reputable telehealth platform with real physician oversight is the most accessible, clinically equivalent alternative. The platforms we've evaluated — starting with DirectMeds — meet the standards that matter: real physician involvement, licensed compounding pharmacy, transparent pricing, ongoing monitoring.

Check if you qualify for compounded semaglutide

DirectMeds is our top-rated platform — real physician oversight, compounded semaglutide from ~$99/month, ships to all 50 states. Free eligibility check takes under 10 minutes.

Check your eligibility at DirectMeds →

Frequently asked questions

Can I use Ozempic for weight loss if I don't have diabetes?
Yes — semaglutide for weight loss is appropriate for non-diabetic patients meeting the BMI criteria (30+, or 27+ with a qualifying condition). Wegovy is the version specifically approved for weight loss in non-diabetic patients. Ozempic is frequently prescribed off-label for weight loss in non-diabetic patients as well. Compounded semaglutide can be prescribed for weight loss by any licensed physician for appropriate candidates.
How long do you have to stay on Ozempic for weight loss?
Current evidence indicates that stopping semaglutide typically leads to weight regain over 12–18 months as appetite returns to baseline. Most obesity medicine specialists now view GLP-1 therapy as a long-term or ongoing treatment for appropriate candidates — similar to how blood pressure medication is managed. This makes the monthly cost an important long-term planning factor.
Is compounded semaglutide as effective as Ozempic?
Yes — at equivalent doses, compounded semaglutide works through the same biological mechanism and produces the same clinical outcomes as brand-name semaglutide. The active molecule is identical. The manufacturing process, regulatory pathway, and cost differ. The drug doing the work in your body is the same.
What happens if I stop taking Ozempic?
Research consistently shows that most patients regain the majority of lost weight within 12–18 months of stopping semaglutide. The biological drivers of appetite and weight — the very mechanisms GLP-1 medications address — return to baseline when the medication stops. This is why the medication is increasingly viewed as a chronic treatment rather than a temporary intervention.